Coordinating Your Regulatory Research Needs
With a 60-year heritage, Hoeford is synonymous with trusted results for the regulatory testing needs of global pharmaceutical companies, vaccine researchers and manufacturers, and biopharmaceutical startups and their investors.
We no longer operate our laboratory in the UK and have partnered with global CRO Medicilon to ensure our customers drug candidates and products meet preclinical safety requirements in the UK, EU, US and other markets.
Integrated Preclinical R&D Packages
In collaboration with Medicilon we offer world-class integrated non-GLP drug candidate development and GLP safety studies across hit identification, synthesis, lead optimisation and candidate selection through to pre-IND safety and efficacy testing.
Our team will help align your business milestones with regulatory requirements.
Standalone Preclinical Studies
When you choose to work with Hoeford and Medicilon, you get access to nearly one million square feet of laboratory space and over 3,000 scientists and support personnel in Shanghai, China and Boston, U.S.A..
This means we can support your drug discovery and development journey by building optimised regulatory strategies that do not compromise on quality or scientific rigour, yet remain efficent and cost-effective.
Featured Article
Choosing your Proof-of-Concept In Vivo Toxicology Laboratory
In Vivo toxicology proof-of-concept (PoC) testing plays a crucial role in evaluating the potential risks and hazards associated with new compounds in the early stages of lead generation and pre-candidate selection, when developers are assessing the likelihood of scientific success, and investors are calculating the likelihood of financial return on their investment.
Choosing the right toxicology testing provider at this stage is an essential step in ensuring that safety, compliance and risk are clearly defined at what can be a nail-biting time for developers and investors.
Featured Service
In Vitro ADME
The 4 Steps of Pharmacokinetics
In the context of Investigational New Drug (IND) applications, in vitro ADME (Absorption, Distribution, Metabolism, and Excretion) testing plays a crucial role in providing essential data and insights that support the safe and effective development of a new drug.
Discover the key reasons why in vitro ADME testing is important in IND applications.
Read More...
More from our Insights and News
Regulatory Toxicology Results You Can Trust
Compliance
We help you design fully-compliant testing programmes that are customised to ensure alignment with the most appropriate regulatory pathway, delivering results that save time and development costs and get your product to market safely.
Excellence
Each new challenge brings together scientific and technical experts with skilled project managers who leverage a long heritage of discipline and commitment to operational excellence, ensuring reliable and predictable outcomes for you and your customers.
Confidence
We act with confidence, determination and a full understanding of your needs and expectations. We communicate with transparency and clarity at every stage of the project to get the results right first time.
Comprehensive
We can conduct one-off and multi-year projects that meet the requirements of UK, EU, US, Australia, Japan, China and other national regulatory bodies, as well as testing for products that require re-testing according to ICH, WHO (Ph. Int.) or other national and supranational pharmacopeia guidelines.